OrthoTrophix

OrthoTrophix is a biopharmaceutical company that develops and commercializes therapies for the treatment of diseases and conditions involving hard tissues such as bone and cartilage. Its candidate disease modifying osteoarthritis drug (DMOAD) is designed to improve function and reduce pathological changes of bone and cartilage structures in knee osteoarthritis (OA) patients.